X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (155) 155
male (113) 113
middle aged (104) 104
female (103) 103
aged (96) 96
risk factors (72) 72
cardiac & cardiovascular systems (53) 53
medicine, general & internal (46) 46
double-blind method (44) 44
abridged index medicus (41) 41
clinical trials (41) 41
cardiovascular disease (39) 39
cardiovascular diseases (39) 39
hypertension (37) 37
treatment outcome (37) 37
peripheral vascular disease (36) 36
prevention (36) 36
risk (35) 35
mortality (33) 33
antihypertensive agents - therapeutic use (29) 29
follow-up studies (29) 29
drug therapy (27) 27
hypertension - drug therapy (27) 27
diabetes (26) 26
cardiovascular diseases - prevention & control (25) 25
cholesterol (25) 25
angiotensin-converting enzyme inhibitors - therapeutic use (24) 24
stroke (24) 24
disease (23) 23
adult (22) 22
atherosclerosis (21) 21
therapy (21) 21
risk assessment (20) 20
diabetes mellitus, type 2 - drug therapy (19) 19
heart failure (19) 19
cardiovascular (18) 18
drug therapy, combination (18) 18
analysis (17) 17
blood pressure (17) 17
care and treatment (17) 17
aged, 80 and over (16) 16
endocrinology & metabolism (16) 16
heart attacks (16) 16
hypertension - complications (16) 16
myocardial-infarction (16) 16
randomized controlled trials as topic (16) 16
cardiovascular diseases - epidemiology (15) 15
health aspects (15) 15
hypolipidemic agents - therapeutic use (15) 15
proportional hazards models (15) 15
research (15) 15
cardiovascular diseases - drug therapy (14) 14
diabetes mellitus (14) 14
dosage and administration (14) 14
time factors (14) 14
type 2 diabetes (14) 14
cardiology (13) 13
cardiovascular diseases - mortality (13) 13
chlorthalidone - therapeutic use (13) 13
glucose (13) 13
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (13) 13
hypoglycemic agents - therapeutic use (13) 13
incidence (13) 13
lipoproteins (13) 13
medical research (13) 13
outcomes (13) 13
patients (13) 13
prospective studies (13) 13
risk-factors (13) 13
trial (13) 13
united states (13) 13
association (12) 12
cerebral infarction (12) 12
diabetes mellitus, type 2 - complications (12) 12
hypercholesterolemia (12) 12
myocardial infarction (12) 12
prevalence (12) 12
progression (12) 12
research design (12) 12
cardiovascular-disease (11) 11
cohort studies (11) 11
coronary-heart-disease (11) 11
kaplan-meier estimate (11) 11
myocardial infarction - prevention & control (11) 11
ramipril (11) 11
regression analysis (11) 11
blood-pressure (10) 10
evaluation (10) 10
events (10) 10
lipid-lowering treatment (10) 10
medicine, research & experimental (10) 10
men (10) 10
ramipril - therapeutic use (10) 10
telmisartan (10) 10
united states - epidemiology (10) 10
african americans (9) 9
amlodipine - therapeutic use (9) 9
angiotensin (9) 9
benzimidazoles - therapeutic use (9) 9
coronary disease - prevention & control (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 23, pp. 2247 - 2257
In this randomized study, the addition of lixisenatide, a glucagon-like peptide 1–receptor agonist, to usual care in patients with type 2 diabetes and a recent... 
MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | GLUCAGON-LIKE PEPTIDE-1 | MYOCARDIAL-INFARCTION | CARDIOVASCULAR OUTCOMES | RECEPTOR AGONISTS | GLUCOSE | DOUBLE-BLIND | FOLLOW-UP | MELLITUS | CONGESTIVE-HEART-FAILURE | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality
Journal Article
JACC: Cardiovascular Imaging, ISSN 1936-878X, 2012, Volume 5, Issue 6, pp. 619 - 625
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2981 - 2997
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 370, Issue 15, pp. 1383 - 1392
Journal Article
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 17, pp. 1575 - 1585
Journal Article